Fortrea Holdings Newsroom

Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fortrea Holdings Inc. (FTRE) and Lexeo Therapeutics, Inc. (LXEO)

TipRanksJul 15 01:44 ET

Fortrea Holdings Analyst Ratings

BenzingaJun 6 09:03 ET

Fortrea Holdings Analyst Ratings

BenzingaMay 29 07:14 ET

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Fortrea Holdings Inc. (FTRE) and Cellectis SA (CLLS)

TipRanksMay 29 05:55 ET

Fortrea Holdings Analyst Ratings

BenzingaMay 28 05:27 ET

Maintaining Hold on Fortrea Holdings Amidst Long-Term Recovery and Current Industry Challenges

TipRanksMay 28 04:39 ET

Fortrea Holdings Analyst Ratings

BenzingaMay 23 13:08 ET

Fortrea Holdings Analyst Ratings

BenzingaMay 14 12:37 ET

Fortrea Holdings Analyst Ratings

BenzingaMay 14 05:58 ET

Baird Upgrades Fortrea Holdings to Outperform, Lowers Price Target to $36

BenzingaMay 14 05:58 ET

Fortrea Holdings Analyst Ratings

BenzingaMar 22 05:50 ET

Baird Initiates Coverage On Fortrea Holdings With Neutral Rating, Announces Price Target of $43

BenzingaMar 22 05:50 ET

Fortrea Holdings Analyst Ratings

BenzingaMar 12 07:22 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)

TipRanksMar 12 05:25 ET

Fortrea Holdings Analyst Ratings

BenzingaMar 6 11:24 ET

Fortrea Holdings Analyst Ratings

BenzingaJan 25 09:44 ET

Fortrea Holdings Analyst Ratings

BenzingaJan 5 10:01 ET

Jefferies Initiates Coverage On Fortrea Holdings With Buy Rating, Announces Price Target of $44

BenzingaJan 4 08:56 ET

Fortrea Holdings Analyst Ratings

BenzingaJan 4 08:54 ET

Analysts Conflicted on These Healthcare Names: Evotec AG (EVO), Collegium Pharmaceutical (COLL) and Fortrea Holdings Inc. (FTRE)

TipRanksJan 4 04:40 ET